|

AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population

RECRUITINGSponsored by China National Center for Cardiovascular Diseases
Actively Recruiting
SponsorChina National Center for Cardiovascular Diseases
Started2025-12-11
Est. completion2026-04-01
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This study aims to evaluate the effectiveness of this facial image-based AI algorithm for screening CAD in high-risk community populations (specifically individuals with diabetes, hypertension, or aged over 65). The main objectives are: 1. To verify if the AI algorithm can accurately distinguish between high-risk and low-risk groups by comparing the actual prevalence of CAD in these groups. 2. To compare the CAD detection rate using this AI screening strategy against the natural detection rate in a real-world cohort.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \>= 18 years.
* Community high-risk population, defined as individuals meeting at least one of the following criteria:

  1. Diagnosed with Diabetes Mellitus;
  2. Diagnosed with Hypertension;
  3. Advanced age (\> 65 years old).

Exclusion Criteria:

* Prior confirmed diagnosis of Coronary Heart Disease (CAD), including clinically diagnosed CAD, history of Coronary Artery Bypass Grafting (CABG), or history of Percutaneous Coronary Intervention (PCI).
* History of diagnosed Heart Failure.
* Significant facial alterations or conditions that may interfere with AI image analysis, such as plastic surgery, severe facial trauma, or heavy makeup.
* Refusal to participate in the study.

Conditions5

Artificial Intelligence AlgorithmsCoronary Artery Disease (CAD)FaceHeart DiseaseScreening

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.